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Introduction
Infants born with congenital diaphragmatic hernia (CDH) have an increased risk of congenital heart malformations, reported in approximately 12-25% of CDH cases (1) (2) (3) (4) (5) (6) (7) . Despite advances in prenatal imaging technology, the greater availability of pediatric cardiac surgery and extra-corporeal oxygenation (ECMO), the prognosis of CDH with heart defects remains poor (3, 7, 8) . Cardiac factors that determine the survival of patients with CDH and heart defect may be secondary to multi-organ involvement or reluctance to undertake surgical corrections, or both (2) .
Accurate information on the total prevalence of CDH and co-morbidities is scarce, mainly due to the exclusion of pregnancy terminations data in previous studies. However, this information would be highly relevant in patient counseling and in making clinical decisions. In this 10-year national retrospective cohort study, we aimed to determine the national total prevalence and prenatal detection rates of CDH with heart defects and the proportions of major extra-cardiac malformations, and to further evaluate the impact of the heart defect severity on survival.
Material and methods
A nationwide 10-year retrospective, registry-based observational cohort study was conducted among cases diagnosed in Finland 2002-2011 with combined CDH and congenital heart defect. The data were obtained from four national registers: Register of Congenital Malformations (FRM), Register on Induced Abortions, Medical Birth Register and Cause-of-Death Statistics.
The FRM is comprehensive; it receives and actively collects data on congenital/fetal malformations of all live births, stillbirths, spontaneous abortions and terminations of pregnancy for severe fetal anomalies from all hospitals, healthcare professionals and cytogenetic laboratories as well as from the national Care Register for Health Care (hospital discharge data). Data on terminations of pregnancy for fetal anomalies are also received from the National Supervisory Authority for Welfare and Health, which, on the pregnant woman's request, can authorize termination of pregnancy for severe fetal anomalies up to the completed gestational week 24. All provided diagnoses are reviewed, classified and coded by a medical geneticist in charge at the FRM. If the diagnosis is unclear, further information is requested from the hospitals concerned. Minor anomalies are principally excluded following the system of the European Surveillance of Congenital Anomalies, (EUROCAT) (9) . The coverage and data quality of the FRM has shown to be reliable in several studies (10, 11) . We cross-checked this cohort data using the unique personal identification codes given to all citizens and residents in Finland.
Outcome factors for the study data were received and reviewed from hospital records, including autopsy reports (newborns and fetuses), prenatal and postnatal cardiology reports, other postnatal medical reports, magnetic resonance imaging (MRI) scans and prenatal and postnatal ultrasounds. All cases with CDH and congenital heart defects were re-evaluated.
Maternal demographics and clinical parameters assessed included maternal age, previous pregnancies and births, gender and birthweight of the affected fetus or child, gestational age, prenatal diagnosis of the CDH and heart defect, stomach in the chest, liver in the chest (reported on ultrasound, surgery or autopsy), additional anomalies and chromosomal results. For those who survived, we assessed for CDH repair and cardiac surgery.
There were 587 961 births (including live births and stillbirths) in 2002-2011 in Finland. According to the FMR, 145 cases with CDH were diagnosed during this 10-year period. Morgagni hernia and diaphragmatic defect as part of Pentalogy of Cantrell were not considered CDH for our study. All cases categorized as diaphragmatic eventration with heart defect were evaluated and included in our dataset if the eventration needed surgical treatment, and these were considered equivalent to a diaphragmatic hernia. Of these 145 cases, there were 80 live births (55%), seven stillbirths (5%), and 58 (40%) terminations of pregnancy. One spontaneous abortion at gestational week 15 with univentricular heart and bilateral diaphragmatic hernia was not included in the original CDH data.
Of the 145 cases with CDH, 37 cases (26%) had a congenital heart defect. We evaluated these cases and included them in the study data. The same senior pediatric and fetal cardiologist (TO) classified all heart defects. By heart defect severity, the cohort was divided into two categories (major and minor defects, Table 1 ). Isolated malposition of heart was not considered a congenital heart defect. Patent foramen ovale and patent ductus arteriosus were included as minor heart defects if operated or if patent ductus
Key message
The survival rate for patients with congenital diaphragmatic hernia and major heart defect is low (11%). The prevalence of hypoplastic left heart syndrome is high. Major extra-cardiac malformations are more frequent than previously reported. arteriosus was treated medically. Hypoplasia of lungs and malrotation of intestine were considered a consequence of a diaphragmatic hernia and were not reported as additional extra-cardiac malformations. The same clinical geneticist (A.R.) classified all major extra-cardiac malformations.
Statistical analyses were performed with IBM SPSS statistics 22.0 (IBM Corp., Armonk, NY, USA). Comparisons of categorical variables between the groups were done by a Chi-square test of independence. Fisher's exact test was used if expected cell values were low. An independent samples t-test was conducted to compare continuous variables between groups. We considered p < 0.05 to be statistically significant. We used EUROCAT instructions to calculate the birth prevalence and the total prevalence of CDH and heart defect as well as proportions of major extra-cardiac malformations in our data (12) .
Ethical approval
The Ethics Committee of Helsinki University Central Hospital approved the study HUS/1938/2016. The National Institute for Health and Welfare THL authorized the use of the health register data in scientific research, as required by the national data protection legislation.
Results
The national total prevalence of CDH was 2.5/10 000 births and live birth prevalence 1.4/10 000 births. With CDH and heart defects the total prevalence was 0.6/ 10 000 births and live birth prevalence 0.3/10 000 births. Of the 37 cases with combined CDH and heart defect, 17 were live births (46%), four stillbirths (11%) and 16 were terminations of pregnancy (43%). Left-sided CDH was more common (32/37, 86%) than right-sided CDH (3/37, 8.1%), p < 0.001 ( Figure 1 ). Almost two-thirds of all CDH cases with a major heart defect (13/20, 65%) had liver herniation into the thoracic cavity; most (17/20, 85%) had left-sided CDH. All cases with hypoplastic left heart syndrome (HLHS) had their liver protruding into the thoracic cavity.
During the study period the prenatal detection rate of CDH was 36% (2002) (2003) (2004) (2005) (2006) and 65% (2007-2011) (p = 0.191). Of all 37 cases with CDH and heart defect, 18 (49%) had a prenatal diagnosis of diaphragmatic hernia and 50% (9/18) had simultaneous prenatal diagnosis of heart defect (two HLHS, two borderline left cardiac ventricles, five ventricular septal defects). Heart defects were found either during the primary prenatal diagnosis of CDH or postnatally; no late pregnancy detections of heart defects were observed. Prenatal diagnosis was obtained before completed gestational week 24 in 41% (15/37) of the cases. In the group of prenatal diagnosis of CDH before 24 weeks, 40% (6/15) were born (one stillbirth and five live births) and 60% (9/15) of cases were terminated; 78% (7/9) of fetuses also had major extracardiac anomalies/anomaly. In the five cases that were terminated for a syndrome or chromosomal anomaly (5/ 16, 31%), the CDH and heart defects were not detected until autopsy. Only one of the liveborn infants with prenatal diagnosis of CDH survived. In addition to CDH and heart defect, major extra-cardiac malformations were observed in 25/37 cases (68%) (Figure 2 ). Major extra-cardiac anomalies were also common in liveborn CDH patients (7/17, 41%). All stillborn cases (4/4; 100%) and most termination of pregnancy cases (14/16; 88%) had major extra-cardiac anomalies. Nine of the 37 cases (24%) had a chromosomal anomaly, including eight trisomy 18, and one Pallister-Killian syndrome. In addition, one had a balanced translocation (5;16).
The mean maternal age was 31.7 years (range 17.9-46.4). Four mothers (4/37, 10.8%) had gestational diabetes, two requiring insulin therapy during pregnancy. One mother (1/37, 2.7%) had asthma, and one (1/37, 2.7%) had hepatitis C and buprenorphine replacement treatment. The clinical characteristics of the mothers of all cases and liveborn patients are presented in Table 2 .
Congenital diaphragmatic hernia and severity of heart defects The proportion of major and minor heart defects was almost equal; 20/37 (54%) cases had a major heart defect and 17/37 (46%) cases had a minor heart defect (Figure 3) . The associated congenital heart defects were diagnosed prenatally in 15/37 (41%) cases. The missed prenatal diagnoses included both major heart defects (11/ 20, 55%) and minor defects (11/17, 65%) (Figure 3) .
In our data, univentricular heart was observed in 7/37 cases (19%). All these cases had HLHS and herniation of the liver into the thoracic cavity. Only one HLHS case had a right-sided diaphragmatic hernia. In the subgroup of CDH patients with heart defect but no extra-cardiac defects, 75% (9/12) had a different level and degree of left-side heart obstructions (4/9 HLHS, 3/9 borderline left ventricle and 2/9 coarctation of aorta). In this cohort, the total prevalence of HLHS (including births and terminations of pregnancy) was 482.8/10 000 births (7/145). Thus, the total prevalence of HLHS was 124 times higher in the study cohort than in the general population of Finland (3.9/10 000 births) (FRM, National Institute for Health and Welfare THL). On the other hand, the live birth prevalence of HLHS in children born with CDH Figure 2 . Major extra-cardiac anomalies in cases with congenital diaphragmatic hernia (CDH) and heart defect (major/minor). ADAM, amniotic band complex; NOS, not otherwise specified; OAVS, oculo-auriculo-vertebral spectrum; TOPFA, termination of pregnancy for fetal anomaly.
[Color figure can be viewed at wileyonlinelibrary.com].
was 500/10 000 liveborn CDH patients. This is 250 times higher than in the general population (2.0/10 000 live births).
Survival of patients with a diaphragmatic hernia and heart defect
In this cohort, the overall survival of patients with CDH and heart defect was 24% (4/17) and was significantly lower than patients with CDH without a heart defect (57%, p = 0.027) (FRM, National Institute for Health and Welfare THL). CDH-patients born with a major Table 2 . Clinical characteristics of all case mothers and liveborn children with congenital diaphragmatic hernia and major or minor congenital heart defect.
Mother (n = 37)
Major heart defects (n = 20) Minor heart defects (n = 17) p-value (two-tailed) Major heart defects (n = 9) Minor heart defects (n = 8) heart defect had a poorer survival prognosis (1/9, 11%) than those born with a minor heart defect (3/8, 38%). In general, all patients who qualified for active care and survived until surgery had a successful recovery. None of the surviving patients had liver herniation into the thoracic cavity. Four liveborn patients with HLHS died during the newborn period. All four surviving patients are presented in Supporting Information Table S1 . Additional major extra-cardiac malformations of the surviving patients are shown in Figure 2 .
Discussion
According to our 10-year data, 26% of all cases with CDH had a concurrent congenital heart defect. Correspondingly, 21% of liveborn children with CDH had an additional heart defect. This result is consistent with previously reported proportions of heart defects in infants with CDH, which varies between 12 and 25% (1-7). The distribution of major (54%) and minor (46%) heart defects in CDH cases was almost equal. Similar to previous studies, we observed an association between liver herniation into the thoracic cavity and HLHS (5, 13, 14) . On the other hand, the major extra-cardiac malformations were more common (68%) than previously reported (2). Prenatal detection rates were surprisingly low, 49% for CDH and 41% for additional heart defects. This is most likely due to the lack of a systematic national screening program of congenital malformations during the early part of the study period Despite advances in prenatal diagnostics, perioperative and operative treatment, the overall survival rate in the subset of CDH patients with congenital heart defect remains low. In our national cohort, all patients who qualified for surgery and survived until the operation had a successful recovery and are currently alive (24% of the liveborn patients). Our observed survival rate is lower than that reported in CDH patients with a congenital heart defect (41%) (3). The survival of CDH patients with a heart defect is significantly lower than of CDH patients without congenital heart defects in Finland (57%) (FRM, National Institute for Health and Welfare THL). As reported in previous studies, the survival rate of liveborn patients was better in those with minor heart defects (38%) than in those with major heart defects (11%) (2, 4) . Our lower survival rates may be due to the exclusion of patients with smaller diaphragmatic defects (Morgagni hernia and diaphragmatic defects in Pentalogy of Cantrell) and further due to low overall prenatal detection rates.
CDH with prenatal diagnosis is known to have a poorer prognosis than CDH detected during pregnancy (15) . In this study, 49% of the liveborn patients with CDH and heart defect were diagnosed prenatally; only one (14%) survived. The survival rate of the liveborn patients without a prenatal CDH diagnosis was better (30%).
Several studies have shown that the mortality risk in children with CDH is related to several factors: prenatal diagnosis, birthweight, gestational age, five-minute Apgar score, patch repair, severity of pulmonary hypoplasia and associated congenital malformations (especially heart defects) (1, 2, 16) . Herniation of the liver into the thoracic cavity is an important prognostic factor for CDH severity (17, 18) . In our study, 65% of all CDH cases with major heart defect, had a liver-up position and, more importantly, liver protrusion into thoracic cavity was found in all HLHS cases. Similar to our study, previous studies have shown an association between chromosomal anomalies and CDH (especially trisomy 18) (2,6,15) Chromosomal defects have been reported in 22% of the cases of CDH without heart defects in Finland (FRM, National Institute for Health and Welfare THL). We found that 41% of liveborn infants and 68% of all cases with CDH and heart defect had major extra-cardiac malformations. The results of liveborn patients were close to the numbers previously reported (33%) (2). The total prevalence was high and, to the best of our knowledge, there are no previous reports including pregnancy terminations.
The combination of CDH and HLHS was also common. The total prevalence of HLHS was 124 times and the live birth prevalence 250 times higher in cases with CDH than in the general population in Finland. However, only 3/7 (43%) cases with CDH and HLHS were detected prenatally. Surprisingly, this is much lower than the detection rate of all HLHS cases (70%) in Finland during the study period (FRM, National Institute for Health and Welfare THL). Main concerns in ultrasound reports were poor acoustic windows and difficulties in detection of the structures due to the heart pressure against the thoracic wall: a low detection rate may be related to difficulties in cardiac evaluation, since all our cases without prenatal diagnosis had liver herniation into the thoracic cavity. A more plausible explanation is that the heart defect severity was progressive and the minor cardiac changes were missed early in pregnancy. Obstructive left-side heart anomalies were as common (38%) as previously reported (2,7). These obstructions in CDH patients may be secondary to impaired left heart filling due to compression of left-side structures, reduction of left-side preload due to pulmonary hypoplasia and distortions of the inferior vena cava flow (2, 14, 18) . A large retrospective study of a cohort of fetuses with CDH suggested that it is primarily the compressive effect that leads to the most severe forms of left-side obstructions. This suggestion was based on the fact that HLHS in fetuses with a right-sided diaphragmatic hernia was not observed 5 . However, in our study, one patient with a right-sided CDH showed HLHS. This observation suggests that not only the compression but also the decreased left heart output, regardless of the side of a diaphragmatic hernia, may play a role in the formation of HLHS in these cases (13) . Repeated follow up of fetal echocardiography may be warranted when planning postnatal care of diaphragmatic hernia, especially in cases with liver protruding into the thoracic cavity.
Reduced survival in patients with single ventricle physiology is expected. The combination of CDH and HLHS has previously been found to have a very poor prognosis (2, 3) . In our cohort, all four liveborn HLHS patients died preoperatively, one family chose compassionate care, and three withdrew active care due to poor response. Furthermore, as in previous studies, the survival of patients with transposition of great arteries and CDH remains poor (2,3). In our cohort, no patients with transposition of great arteries and CDH were operated on or survived.
Because of the retrospective nature of this 10-year national cohort, one limitation of this study is that the classification of heart defects and extra-cardiac malformations is based on written descriptions of anomalies only. Furthermore, in some cases (n = 5), an autopsy after death or termination of pregnancy was not performed; these CDH and cardiac diagnoses were thus based only on prenatal or postnatal ultrasound scans. Unfortunately we could not assess the level of liver protrusion into the thoracic cavity due to scarce reporting policy. Because of lack of systematic national follow-up guidelines, the progression of the heart condition could not be evaluated.
Conclusions
This study showed that CDH patients born with a major heart defect had a worse survival prognosis (11%) than those with a minor heart defect (38%). Hypoplastic left heart syndrome was more common in left-sided CDH. The total prevalence of HLHS in the CDH-cases was 124 times higher than in the general population. No patients with HLHS survived. The combination of liver herniation and cardiac defect had a dismal prognosis in our population. In addition to congenital heart defect and CDH, major extra-cardiac malformations in liveborn children were common (41%). When terminations of pregnancy were included, major extra-cardiac malformations were even more common (68%).
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